CTN 240: VALIDATE trial

Read More

CTN 239: Phase II study of AGS-004 an immunotherapeutic agent in combination with ART followed by ART interruption

Read More

CTN 238: The MAINTAIN study

Read More

CTN 237: Influenza vaccination strategies using Fluviral in HIV-positive adults

Read More

CTN 236: HPV vaccine in HIV positive girls and women

Read More

CTN 233: Pharmacokinetics of antiretroviral therapy (ARV) in HIV-positive women

Read More

CTN 229: Effect of AGS-004 immunotherapeutic agent in HIV-positive people on HAART

Read More

CTN 227: Hepatitis C therapeutic vaccine

Read More